BlueJay Mobile-Health, Inc. – Trademark Portfolio
Entity Type: 03
BlueJay Mobile-Health, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include BLUEJAYENGAGE and BLUEJAYTELEHEALTH. The owner is based in Orinda, CA.
595 Dalewood Dr
Orinda, CA 94563
Showing of trademarks Trademarks
Trademark Classifications
BlueJay Mobile-Health, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does BlueJay Mobile-Health, Inc. have?
BlueJay Mobile-Health, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 1 cancelled.
What trademark classes does BlueJay Mobile-Health, Inc. file in?
BlueJay Mobile-Health, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are BlueJay Mobile-Health, Inc.'s most well-known trademarks?
BlueJay Mobile-Health, Inc.'s registered trademark portfolio includes well-known marks such as BLUEJAYENGAGE and BLUEJAYTELEHEALTH. These are among 2 currently registered trademarks in the portfolio.
What is BlueJay Mobile-Health, Inc.'s trademark registration success rate?
BlueJay Mobile-Health, Inc. has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.